These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 10080918

  • 1. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N, Udagawa N, Suda T.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):449-55. PubMed ID: 10080918
    [Abstract] [Full Text] [Related]

  • 2. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM.
    J Bone Miner Res; 2000 Apr 24; 15(4):640-9. PubMed ID: 10780856
    [Abstract] [Full Text] [Related]

  • 3. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.
    Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ.
    Endocr Rev; 1999 Jun 24; 20(3):345-57. PubMed ID: 10368775
    [Abstract] [Full Text] [Related]

  • 4. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 24; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 5. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
    Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T.
    Biochem Biophys Res Commun; 1998 May 08; 246(1):199-204. PubMed ID: 9600092
    [Abstract] [Full Text] [Related]

  • 6. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.
    Arthritis Rheum; 2000 Feb 08; 43(2):259-69. PubMed ID: 10693864
    [Abstract] [Full Text] [Related]

  • 7. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T, Utsuyama M, Hirokawa K.
    J Bone Miner Res; 2001 Aug 08; 16(8):1416-25. PubMed ID: 11499864
    [Abstract] [Full Text] [Related]

  • 8. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 08; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 9. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.
    Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K.
    Biochem Biophys Res Commun; 1998 Dec 18; 253(2):395-400. PubMed ID: 9878548
    [Abstract] [Full Text] [Related]

  • 10. Regulation of the differentiation and function of osteoclasts.
    Chambers TJ.
    J Pathol; 2000 Sep 18; 192(1):4-13. PubMed ID: 10951393
    [Abstract] [Full Text] [Related]

  • 11. Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand.
    Xu J, Tan JW, Huang L, Gao XH, Laird R, Liu D, Wysocki S, Zheng MH.
    J Bone Miner Res; 2000 Nov 18; 15(11):2178-86. PubMed ID: 11092398
    [Abstract] [Full Text] [Related]

  • 12. The molecular basis of osteoclast differentiation and activation.
    Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N.
    Novartis Found Symp; 2001 Nov 18; 232():235-47; discussion 247-50. PubMed ID: 11277084
    [Abstract] [Full Text] [Related]

  • 13. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 18; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 14. Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.
    Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H, Hikita A, Nakamura K, Tanaka S, Furukawa H.
    J Exp Med; 2003 Apr 21; 197(8):1029-35. PubMed ID: 12707301
    [Abstract] [Full Text] [Related]

  • 15. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM, Pearse RN.
    Cancer; 2003 Feb 01; 97(3 Suppl):802-12. PubMed ID: 12548579
    [Abstract] [Full Text] [Related]

  • 16. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption.
    Aubin JE, Bonnelye E.
    Medscape Womens Health; 2000 Mar 01; 5(2):5. PubMed ID: 10792853
    [Abstract] [Full Text] [Related]

  • 17. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.
    Bone; 1999 Nov 01; 25(5):517-23. PubMed ID: 10574571
    [Abstract] [Full Text] [Related]

  • 18. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V, Faust J, Boyle WJ, Dunstan CR, Kelley M, Kaufman S, Scully S, Van G, Lacey DL.
    J Cell Biochem; 1999 Feb 01; 72(2):251-61. PubMed ID: 10022507
    [Abstract] [Full Text] [Related]

  • 19. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF).
    Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):697-702. PubMed ID: 9837769
    [Abstract] [Full Text] [Related]

  • 20. A novel molecular mechanism modulating osteoclast differentiation and function.
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T, Higashio K.
    Bone; 1999 Jul 27; 25(1):109-13. PubMed ID: 10423033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.